Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check3 days agoChange DetectedThe page appears to have a visual/layout update without changes to core study details like criteria, outcomes, or locations.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Lung cancer, reducing genetics content coverage on that disease.SummaryDifference0.1%

- Check31 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check38 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

- Check53 days agoChange Detected- Revision updated to v3.0.2, replacing v3.0.1. - The 'Back to Top' link was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.